Lisa Bero, PhD

Professor
Clinical Pharmacy
+1 415 476-1067

Lisa A. Bero, PhD, Professor, Department of Clinical Pharmacy, School of Pharmacy and Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. She has developed and validated methods for assessing bias in the design, conduct and dissemination of research on pharmaceuticals, tobacco and chemicals. Dr. Bero has also conducted analyses to examine the dissemination and policy implications of research evidence. Her international activities include advisor to the World Health Organization Department of Essential Medicines and Pharmaceutical Policies, member and chair of the WHO Essential Medicines Committee and member of the Pan American Health Organization Advisory Committee on Health Research. She is Director of the San Francisco Branch of the United States Cochrane Center and the World Health Organization Collaborating Centre on Pharmaceutical Research and Science Policy. She was an elected member of the Cochrane Collaboration Steering Group for 12 years and was appointed Co-Chair in 2013. Dr. Bero serves on several national and international committees related to conflicts of interest and research, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice.

Publications: 

A Social Network Analysis of the Financial Links Backing Health and Fitness Apps.

American journal of public health

Grundy Q, Held F, Bero L

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

BMJ open

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA

Medicine shortages in Fiji: A qualitative exploration of stakeholders' views.

PloS one

Walker J, Chaar BB, Vera N, Pillai AS, Lim JS, Bero L, Moles RJ

Industry sponsorship and research outcome.

The Cochrane database of systematic reviews

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L

The ties that bind.

BMJ (Clinical research ed.)

Lundh A, Bero L

Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.

The Cochrane database of systematic reviews

Apollonio D, Philipps R, Bero L

A call to action to reshape evidence synthesis and use for nutrition policy.

The Cochrane database of systematic reviews

Lawrence M, Naude C, Armstrong R, Bero L, Covic N, Durao S, Ghersi D, Macdonald G, MacLehose H, Margetts B, Tovey D, Volmink J, Young T

Systematic Review: A Method at Risk for Being Corrupted.

American journal of public health

Bero L

The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner?

JAMA internal medicine

Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L

GRADE Methods for Guideline Development: Time to Evolve?

Annals of internal medicine

Norris SL, Bero L

A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.

Environmental health : a global access science source

Vandenberg LN, Ågerstrand M, Beronius A, Beausoleil C, Bergman Å, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, Jobling S, Kidd KA, Kortenkamp A, Macleod MR, Martin OV, Norinder U, Scheringer M, Thayer KA, Toppari J, Whaley P, Woodruff TJ, Rudén C

Implementation plans included in World Health Organisation guidelines.

Implementation science : IS

Wang Z, Norris SL, Bero L

Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan.

Environment international

Johnson PI, Koustas E, Vesterinen HM, Sutton P, Atchley DS, Kim AN, Campbell M, Donald JM, Sen S, Bero L, Zeise L, Woodruff TJ

GRADE: Assessing the quality of evidence in environmental and occupational health.

Environment international

Morgan RL, Thayer KA, Bero L, Bruce N, Falck-Ytter Y, Ghersi D, Guyatt G, Hooijmans C, Langendam M, Mandrioli D, Mustafa RA, Rehfuess EA, Rooney AA, Shea B, Silbergeld EK, Sutton P, Wolfe MS, Woodruff TJ, Verbeek JH, Holloway AC, Santesso N, Schünemann HJ

Informatics: Make sense of health data.

Nature

Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, Macleod M, Tovey D, Tugwell P, White H, Sim I

A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance.

Journal of clinical epidemiology

Alexander PE, Gionfriddo MR, Li SA, Bero L, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Norris SL, Schünemann HJ, Thabane L, Guyatt GH

Public Opinions about Overdiagnosis: A National Community Survey.

PloS one

Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K

Regulatory agencies hold the key to improving Cochrane reviews of drugs.

The Cochrane database of systematic reviews

Schroll JB, Bero L

Reply to Margalida and Colomer: Science should strive to prevent mistakes, not corrections.

Proceedings of the National Academy of Sciences of the United States of America

Siler K, Lee K, Bero L

A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents.

Health policy (Amsterdam, Netherlands)

Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C

Expensive medicines: ensuring objective appraisal and equitable access.

Bulletin of the World Health Organization

Hill SR, Bero L, McColl G, Roughead E

Measuring the effectiveness of scientific gatekeeping.

Proceedings of the National Academy of Sciences of the United States of America

Siler K, Lee K, Bero L

World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance.

Journal of clinical epidemiology

Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, Stoltzfus R, Montori VM, Norris SL, Schünemann HJ, Guyatt GH

Bias related to funding source in statin trials.

BMJ (Clinical research ed.)

Bero L

Systematic reviews: perhaps "the answer to policy makers' prayers"?

Environmental health perspectives

Fox DM, Bero L

On WHO's essential medicines process and transparency.

BMJ (Clinical research ed.)

Magrini N, Robertson J, de Joncheere K, Bero L

A clearer view of evidence in treating macular degeneration: off-label policies and independent research.

The Cochrane database of systematic reviews

Formoso G, Marata AM, Magrini N, Bero L

Side effects are incompletely reported among systematic reviews in gastroenterology.

Journal of clinical epidemiology

Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC

Evidence based medicine: looking forward and building on what we have learnt.

BMJ (Clinical research ed.)

Tovey D, Churchill R, Bero L

Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.

The Cochrane database of systematic reviews

Anglemyer A, Horvath HT, Bero L

Staff perceptions of an on-site clinical pharmacist program in an academic emergency department after one year.

The western journal of emergency medicine

Coralic Z, Kanzaria HK, Bero L, Stein J

Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond.

Environmental health perspectives

Krauth D, Woodruff TJ, Bero L

World Health Organization recommendations are often strong based on low confidence in effect estimates.

Journal of clinical epidemiology

Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R, Djulbegovic B, Neumann I, Rave S, Guyatt G

Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance.

JAMA internal medicine

Neltner TG, Alger HM, O'Reilly JT, Krimsky S, Bero LA, Maffini MV

Availability, prices and affordability of essential medicines in Haiti.

Journal of global health

Chahal HS, St Fort N, Bero L

Term limits and the tobacco industry.

Social science & medicine (1982)

Apollonio DE, Glantz SA, Bero LA

Searching for unpublished data for Cochrane reviews: cross sectional study.

BMJ (Clinical research ed.)

Schroll JB, Bero L, Gøtzsche PC

Review of the quality of pediatric medications in developing countries.

Journal of pharmaceutical sciences

Conway J, Bero L, Ondari C, Wasan KM

The cycle of bias in health research: a framework and toolbox for critical appraisal training.

Accountability in research

Odierna DH, Forsyth SR, White J, Bero LA

Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners.

Health expectations : an international journal of public participation in health care and health policy

Odierna DH, White J, Forsyth S, Bero LA

Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia.

BMC health services research

Taba P, Rosenthal M, Habicht J, Tarien H, Mathiesen M, Hill S, Bero L

Industry sponsorship and research outcome.

The Cochrane database of systematic reviews

Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L

Measuring the performance of the Cochrane library.

The Cochrane database of systematic reviews

Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Smith R, Tovey D

The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines.

Journal of clinical epidemiology

Bero LA, Hill S, Habicht J, Mathiesen M, Starkopf J

Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study.

BMJ (Clinical research ed.)

Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD

Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography.

Journal of clinical epidemiology

Norris SL, Burda BU, Holmer HK, Ogden LA, Fu R, Bero L, Schünemann H, Deyo R

Conrad and Becker's "10 Criteria" fall short of addressing conflicts of interest in chemical safety studies.

Environmental health perspectives

Sutton P, Woodruff TJ, Vogel S, Bero LA

Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency.

Revista panamericana de salud pu´blica = Pan American journal of public health

Krleža-Jeriç K, Lemmens T, Reveiz L, Cuervo LG, Bero LA

Applying the essential medicines concept to US preferred drug lists.

American journal of public health

Millar TP, Wong S, Odierna DH, Bero LA

Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.

JAMA

Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD

Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices.

Circulation. Cardiovascular quality and outcomes

Dhruva SS, Bero LA, Redberg RF

Making systematic reviews global.

The Cochrane database of systematic reviews

Bero L, Ghersi D

The Cochrane Library Oversight Committee.

The Cochrane database of systematic reviews

Smith R, Tovey D, Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Pais P

To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008.

Bulletin of the World Health Organization

Bero L, Carson B, Moller H, Hill S

CONSORT 2010.

Lancet (London, England)

Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L

Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.

The Cochrane database of systematic reviews

Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L

Outcome reporting in industry-sponsored trials of gabapentin for off-label use.

The New England journal of medicine

Vedula SS, Bero L, Scherer RW, Dickersin K

Mandatory disclosure of pharmaceutical industry-funded events for health professionals.

PLoS medicine

Robertson J, Moynihan R, Walkom E, Bero L, Henry D

The politics of smoking in federal buildings: an executive order case study.

American journal of public health

Cook DM, Bero LA

Moral disengagement in the corporate world.

Accountability in research

White J, Bandura A, Bero LA

Clarification of study and citation.

Archives of internal medicine

Finley PR, Bero L

Reporting science and conflicts of interest in the lay press.

PloS one

Cook DM, Boyd EA, Grossmann C, Bero LA

Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

White J, Parascandola M, Bero L

Participation and argument in legislative debate on statewide smoking restrictions.

Health research policy and systems / BioMed Central

Apollonio DE, Lopipero P, Bero LA

The tobacco industry and the Data Quality Act.

Science (New York, N.Y.)

Schick SF, Bero LA, Cook DM

WITHDRAWN: Printed educational materials: effects on professional practice and health care outcomes.

The Cochrane database of systematic reviews

Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA

[Shall we ban industrial funds for research?].

Epidemiologia e prevenzione

Bero L

Characteristics and impact of drug detailing for gabapentin.

PLoS medicine

Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA

Evidence based medicine: increasing, not dictating, choice.

BMJ (Clinical research ed.)

Dickersin K, Straus SE, Bero LA

Improving the use of research evidence in guideline development: 4. Managing conflicts of interests.

Health research policy and systems / BioMed Central

Boyd EA, Bero LA

Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

Annals of internal medicine

Steinman MA, Bero LA, Chren MM, Landefeld CS

Tobacco industry sponsorship of a book and conflict of interest.

Addiction (Abingdon, England)

Hong MK, Bero LA

Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals.

The Medical journal of Australia

Lee KP, Boyd EA, Holroyd-Leduc JM, Bacchetti P, Bero LA

Identifying carcinogens: the tobacco industry and regulatory politics in the United States.

International journal of health services : planning, administration, evaluation

Cook DM, Bero LA

The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke.

Health affairs (Project Hope)

Cook DM, Tong EK, Glantz SA, Bero LA

The limits of competing interest disclosures.

Tobacco control

Bero LA, Glantz S, Hong MK

Tobacco industry manipulation of research.

Public health reports (Washington, D.C. : 1974)

Bero LA

Managing financial conflicts of interest in research.

The Journal of the American College of Dentists

Bero LA

Legislating "sound science": the role of the tobacco industry.

American journal of public health

Baba A, Cook DM, McGarity TO, Bero LA

Conflicts of interest in academic research: policies, processes, and attitudes.

Accountability in research

Lipton S, Boyd EA, Bero LA

Implementation of financial disclosure policies to manage conflicts of interest.

Health affairs (Project Hope)

Boyd EA, Lipton S, Bero LA

Creating a text data-mining application for use in public health informatics.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference

Michel MC, Bero LA, Bright T

Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial.

Pharmacotherapy

Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA

Financial conflict-of-interest policies in clinical research: issues for clinical investigators.

Academic medicine : journal of the Association of American Medical Colleges

Boyd EA, Cho MK, Bero LA

Systematic reviews of the effectiveness of quality improvement strategies and programmes.

Quality & safety in health care

Grimshaw J, McAuley LM, Bero LA, Grilli R, Oxman AD, Ramsay C, Vale L, Zwarenstein M

Chasing the dollar: why scientists should decline tobacco industry funding.

Journal of epidemiology and community health

Malone RE, Bero LA

Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

BMJ (Clinical research ed.)

Lexchin J, Bero LA, Djulbegovic B, Clark O

Framing processes in public commentary on US federal tobacco control regulation.

Social studies of science

Roth AL, Dunsby J, Bero LA

Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer.

Pharmacotherapy

Beney J, Devine EB, Chow V, Ignoffo RJ, Mitsunaga L, Shahkarami M, McMillan A, Bero LA

Impact of a collaborative pharmacy practice model on the treatment of depression in primary care.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA

Comparison of review articles published in peer-reviewed and throwaway journals.

JAMA

Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH

Prevalence of honorary and ghost authorship in Cochrane reviews.

JAMA

Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanagin A, Yank V, MacLennan G, Gøtzsche PC, Bero LA

Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland.

Public health reports (Washington, D.C. : 1974)

Montini T, Mangurian C, Bero LA

High school journalists' perspectives on tobacco.

Journal of health communication

Malone RE, Wenger LD, Bero LA

The Criticism Management System for the Cochrane Library.

Evaluation & the health professions

Ober M, Shohara R, Rennie D, Yank V, Bero LA

Evaluating public commentary and scientific evidence submitted in the development of a risk assessment.

Risk analysis : an official publication of the Society for Risk Analysis

Schotland MS, Bero LA

Cigar magazines: using tobacco to sell a lifestyle.

Tobacco control

Wenger LD, Malone RE, George A, Bero LA

Changing provider behavior: an overview of systematic reviews of interventions.

Medical care

Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA

"Educational" advertisements--I haven't seen one yet!

The Western journal of medicine

Bero LA

The cigar revival and the popular press: a content analysis, 1987-1997.

American journal of public health

Wenger L, Malone R, Bero L

Music to be born to, music to die to.

BMJ (Clinical research ed.)

Anderson J, Baum M, Bero LA, Chalmers I, Chapman S, Deary IJ, Ebrahim S, Evans M, Farrell M, Greaves D, Higginson I, Hippisley-Cox J, James B, McKenzie H, Macaulay AC, Rabow M, Smyth RL, Stores G, Wolpert L

Coverage by the news media of the benefits and risks of medications.

The New England journal of medicine

Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB

Cigars, youth, and the Internet link.

American journal of public health

Malone RE, Bero LA

Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.

The Cochrane database of systematic reviews

Bero LA, Mays NB, Barjesteh K, Bond C

Printed educational materials: effects on professional practice and health care outcomes.

The Cochrane database of systematic reviews

Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA

Print media coverage of research on passive smoking.

Tobacco control

Kennedy GE, Bero LA

EUR-ASSESS Project Subgroup Report on Dissemination and Impact.

International journal of technology assessment in health care

Granados A, Jonsson E, Banta HD, Bero L, Bonair A, Cochet C, Freemantle N, Grilli R, Grimshaw J, Harvey E, Levi R, Marshall D, Oxman A, Pasart L, Räisänen V, Rius E, Espinas JA

GPs' prescribing behaviour may be affected by drug promotion.

BMJ (Clinical research ed.)

Gill PS, Freemantle N, Bero L, Haaijer-Ruskamp F, Markela M, Barjesteh KP

The quality of drug studies published in symposium proceedings.

Annals of internal medicine

Cho MK, Bero LA

Dear doctor ... regarding calcium channel blockers.

JAMA

Stryer DB, Lurie P, Bero LA

Improving the use of information in medical effectiveness research.

International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua

Phillips KA, Bero LA

Influences on the quality of published drug studies.

International journal of technology assessment in health care

Bero LA, Rennie D

Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study.

Lancet (London, England)

de Vries TP, Henning RH, Hogerzeil HV, Bapna JS, Bero L, Kafle KK, Mabadeje Af, Santoso B, Smith AJ

The publication of commercially supported supplements statement.

Anesthesia and analgesia

Hornbein T, Bero L, Rennie D

Nicotine and addiction. The Brown and Williamson documents.

JAMA

Slade J, Bero LA, Hanauer P, Barnes DE, Glantz SA

Environmental tobacco smoke. The Brown and Williamson documents.

JAMA

Barnes DE, Hanauer P, Slade J, Bero LA, Glantz SA

Health care cost effects of public use of a regional poison control center.

The Western journal of medicine

Kearney TE, Olson KR, Bero LA, Heard SE, Blanc PD

Drug promotion.

The New England journal of medicine

Stryer DB, Bero LA

Sponsored symposia on environmental tobacco smoke.

JAMA

Bero LA, Galbraith A, Rennie D

Assessing the appropriateness of physician prescribing for geriatric outpatients. Development and testing of an instrument.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Lipton HL, Bird JA, Bero LA, McPhee SJ

The publication of sponsored symposiums in medical journals.

The New England journal of medicine

Bero LA, Galbraith A, Rennie D

Throw it away, Sam: the controlled circulation journals.

AJR. American journal of roentgenology

Rennie D, Bero LA

Perinatal effects of drugs of abuse.

Federation proceedings

Braude MC, Szeto HH, Kuhn CM, Bero L, Ignar D, Field E, Lurie S, Chasnoff IJ, Mendelson JH, Zuckerman B

Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.

The Journal of pharmacology and experimental therapeutics

Bero LA, Kuhn CM

Role of serotonin in opiate-induced prolactin secretion and antinociception in the developing rat.

The Journal of pharmacology and experimental therapeutics

Bero LA, Kuhn CM

Endocrine consequences of perinatal methadone exposure.

NIDA research monograph

Kuhn C, Bero L, Ignar D, Lurie S, Field E

Catecholaminergic regulation of opiate-stimulated growth hormone secretion in the developing rat.

The Journal of pharmacology and experimental therapeutics

Bero LA, Kuhn CM